These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33298751)

  • 1. Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy.
    Curtis M; Larney S; Higgs P; Cossar RD; Winter RJ; Stewart AC; Stoové M
    J Addict Med; 2021 Nov-Dec 01; 15(6):525-526. PubMed ID: 33298751
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
    Stöver H; Jamin D; Michels II; Knorr B; Keppler K; Deimel D
    Harm Reduct J; 2019 Dec; 16(1):72. PubMed ID: 31864356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
    Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
    Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths.
    Larney S; Degenhardt L; Farrell M
    Addiction; 2016 Mar; 111(3):560-1. PubMed ID: 26589456
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.
    Roberts J; White B; Attalla D; Ward S; Dunlop AJ
    Addiction; 2021 Feb; 116(2):426-427. PubMed ID: 32888226
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.
    Böhmer K; Schecke H; Render I; Scherbaum N
    Subst Abuse Treat Prev Policy; 2020 Mar; 15(1):21. PubMed ID: 32156295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.
    Chandra DK; Bazazi AR; Nahaboo Solim MA; Kamarulzaman A; Altice FL; Culbert GJ
    HIV Res Clin Pract; 2019 Feb; 20(1):12-23. PubMed ID: 31303149
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid substitution treatment in Tihar prisons, India: Process of implementation.
    Jhanjee S; Pant S; Girdhar NK; Sethi H; Gunasekaran Rengaswamy R; Jain R; Sarangi J
    Int J Drug Policy; 2015 Sep; 26(9):890-1. PubMed ID: 26123894
    [No Abstract]   [Full Text] [Related]  

  • 10. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007-2013.
    Larney S; Lai W; Dolan K; Zador D
    J Subst Abuse Treat; 2016 Nov; 70():58-63. PubMed ID: 27692189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on Degenhardt et al. (2014): Access to opioid substitution therapy in prison is not enough-the crucial role of post-release retention in preventing drug-related harms.
    Stoové M; Kinner S
    Addiction; 2014 Aug; 109(8):1318-9. PubMed ID: 25041202
    [No Abstract]   [Full Text] [Related]  

  • 13. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
    Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
    Addiction; 2021 Dec; 116(12):3473-3481. PubMed ID: 33999458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.
    Finlay AK; Harris AH; Rosenthal J; Blue-Howells J; Clark S; McGuire J; Timko C; Frayne SM; Smelson D; Oliva E; Binswanger I
    Drug Alcohol Depend; 2016 Mar; 160():222-6. PubMed ID: 26832998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid pharmacotherapy in criminal justice settings: now is the time.
    Lee JD; Rich JD
    Subst Abus; 2012; 33(1):1-4. PubMed ID: 22263707
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
    Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
    Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.
    Macmadu A; Goedel WC; Adams JW; Brinkley-Rubinstein L; Green TC; Clarke JG; Martin RA; Rich JD; Marshall BDL
    Drug Alcohol Depend; 2020 Mar; 208():107858. PubMed ID: 32050112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review.
    Ludwig AS; Peters RH
    Int J Drug Policy; 2014 Nov; 25(6):1041-6. PubMed ID: 25249444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
    Farahmand P; Modesto-Lowe V; Chaplin MM
    J Am Acad Psychiatry Law; 2017 Dec; 45(4):472-477. PubMed ID: 29282239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing Opioid Agonist Treatment in Correctional Facilities.
    Fiscella K; Wakeman SE; Beletsky L
    JAMA Intern Med; 2018 Sep; 178(9):1153-1154. PubMed ID: 30073242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.